About The University of Pennsylvania Cancer Center
Philadelphia is home to one of the world’s premier cancer treatment centers, the Abramson Cancer Center of the University of Pennsylvania. This renowned cancer center currently sees more than 70,000 outpatient visits as well as 9,000 inpatient discharges.
While every form of cancer and related conditions are treated at the Abramson Cancer Center, there is a particular focus on the care and treatment of mesothelioma
and related pleural diseases at Penn Medicine’s Mesothelioma and Pleural Program. This multidisciplinary community of medical and surgical experts collaborates to diagnose, treat and educate patients as they adjust to the emotional and physical side effects of the disease.
The team includes such noted physicians as Corey J. Langer, M.D.
, director of Thoracic Oncology, who specializes in lung cancer, mesothelioma and other thoracic malignancies and Joseph Friedberg, M.D.
chief of the Division of Thoracic Surgery at Penn Presbyterian Medical Center.
When it comes to mesothelioma treatment, Penn’s Mesothelioma and Pleural Program has access to the latest, most advanced surgical and medical techniques, ensuring personalized patient outcomes with an emphasis on minimally invasive procedures. Among these are:
- Surgeries, including extrapleural pneumonectomy, thoracotomies and video-assisted thoracoscopic surgery (VATS)
- Radiation, including brachytherapy, photodynamic therapy (PDT) and proton therapies (an advanced form of radiation therapy, delivered at the Penn Medicine’s Roberts Proton Therapy Center, the largest in the world
- Chemotherapy and Biologic therapies, including combination chemotherapy and immunotherapy
- Targeted therapies, including gene and adjuvant therapies
- Interventional pulmonology treatments, including endobronchial ultrasound-guided biopsy and mediastinal staging pleuroscopy
Research & Clinical Trials
Research is crucial to the diagnosis and treatment of lung cancer
and thoracic conditions, and Abramson’s program is considered among the world’s most accomplished. A coordinated approach is the hallmark. It relies on collaboration from professionals representing various disciplines and modalities, along with more than 400 basic, translational and clinical scientists.
The Penn University System’s involvement provides doctors and patients with a host of medical and educational resources. In regard to mesothelioma and related diseases, this relationship allows for a better understanding of the genetic links. All mesothelioma patients are given the option to participate in clinical trials.
The Abramson Cancer Center is located within the Ruth and Raymond Perelman Center for Advanced Medicine, a state-of-the-art outpatient facility housing oncology, pulmonology, radiation and surgery.
Abramson Cancer Center is one 40 U.S. facilities designated as a Comprehensive Cancer Center, which is an honor bestowed by the National Cancer Institute (NCI) to institutions maintaining the highest standards of excellence in patient care, education, basic science, clinical research and cancer prevention.
Disclaimer: Penn Medicine Abramson Cancer Center has no professional affiliation with Asbestos.com.